DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company will participate in the following upcoming conferences: Citi 2026 Global Consumer & Retail Conference D…
STAMFORD, Conn–(BUSINESS WIRE)–TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today the treatment of the initial patient for its first-in-human clinical trial evaluating the company’s groundbreaking quantitative corneal …
WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, Marguerite B. McDonald, MD, FACS, discusses the use of DefEYE’s Biovance 3L Ocular decellularized basement membrane for the treatment of neurotrophic keratitis.“It works,” McDonald, …
WOODBRIDGE, Conn.–(BUSINESS WIRE)–LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, is advancing its commercialization efforts by pre-booking …
HOUSTON–(BUSINESS WIRE)–Starlab Space LLC, the commercial space station developer expanding access to low Earth orbit research, today announced a reservation agreement with LambdaVision, a biotechnology company developing a protein-based artificial r…
Physicians in the U.S. are only marginally more likely to die at home or in hospice than other Americans, according to study results.“There have been considerable public health efforts aimed at reducing intensive care at the end of life,” lead author V…